Related Experiment Video
Updated: Jun 21, 2026

Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
The induction of senescence-like growth arrest by protein kinase C-activating diterpene esters in solid tumor cells
Sharon A Mason1, Sarah-Jane Cozzi, Carly J Pierce
1Drug Discovery Group, Queensland Institute of Medical Research, Post Office Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia.
Abstract:
We previously identified the induction of senescence in melanoma cell lines sensitive to diterpene esters, indicating a therapeutic potential. Here we compared the cytostatic effects of two diterpene esters: the prototypic PKC-activating drug TPA (12-O-tetradecanoylphorbol-13-acetate), and the novel compound PEP008 (20-O-acetyl-ingenol-3-angelate) in cell lines derived from melanoma, breast cancer and colon cancer. The diterpene esters induced permanent growth arrest with characteristics of senescence in a subset of cell lines in all three solid tumor models at 100-1000 ng/ml. Use of the PKC inhibitor bisindolylmaleimide-l demonstrated that activation of PKC was required for growth arrest. Full genome expression profiling identified pivotal genes involved in DNA synthesis and cell cycle control down-regulated by treatment in all three sensitive tumor models. At the protein level, prolonged down-regulation of E2F-1 and proliferating cell nuclear antigen (PCNA), sustained expression of p21(WAF1/CIP1) and dephosphorylation of retinoblastoma (Rb) occurred in the sensitive cells. Additionally, the type II tumor suppressor HRASLS3, which has a role in mitogen-activated protein kinase (MAPK) pathway suppression, was constitutively elevated in cell lines resistant to the senescence effects compared to their sensitive counterparts. Together, these results demonstrate that both TPA and the novel PKC-activating drug PEP008 induce growth arrest with characteristics of senescence in solid tumor cell lines derived from a variety of tissue types, and by a similar mechanism. PKC-activating diterpene esters may therefore have therapeutic potential in a subset of breast cancer, colon cancer and melanoma tumors.
Insights
PKC-activating diterpene esters, like TPA and PEP008, induce senescence and permanent growth arrest in melanoma, breast, and colon cancer cells. This mechanism, involving specific gene and protein changes, suggests potential therapeutic applications.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Diterpene esters have shown potential in inducing senescence in melanoma.
- Senescence, a state of permanent cell cycle arrest, is a key mechanism in tumor suppression.
Purpose of the Study:
- To compare the cytostatic effects of TPA and PEP008 diterpene esters in melanoma, breast, and colon cancer cell lines.
- To elucidate the mechanism of action, including the role of Protein Kinase C (PKC) activation and downstream molecular changes.
Main Methods:
- Treatment of solid tumor cell lines with TPA and PEP008 at varying concentrations.
- Inhibition of PKC using bisindolylmaleimide-I to assess its role in growth arrest.
- Genome-wide expression profiling to identify affected genes.
- Protein analysis to evaluate key cell cycle regulators (E2F-1, PCNA, p21(WAF1/CIP1), Rb).
Main Results:
- Diterpene esters induced senescence and permanent growth arrest in a subset of cell lines across all three cancer types.
- PKC activation was essential for the observed growth arrest.
- Down-regulation of DNA synthesis and cell cycle control genes, along with specific protein alterations (E2F-1, PCNA, p21(WAF1/CIP1), Rb), were observed in sensitive cells.
- Elevated HRASLS3 levels in resistant cell lines suggest a role in resistance mechanisms.
Conclusions:
- Both TPA and PEP008 effectively induce senescence and growth arrest in diverse solid tumor cell lines via a similar PKC-dependent mechanism.
- PKC-activating diterpene esters represent a promising therapeutic strategy for a subset of breast cancer, colon cancer, and melanoma patients.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Replicative Cell Senescence
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules

